Follow-up results in tuberculous cervical lymphadenitis

dc.contributor.authorOktay, MF
dc.contributor.authorTopcu, I
dc.contributor.authorSenyigit, A
dc.contributor.authorBilici, A
dc.contributor.authorArslan, A
dc.contributor.authorCureoglu, S
dc.contributor.authorYildirim, M
dc.date.accessioned2024-04-24T16:19:02Z
dc.date.available2024-04-24T16:19:02Z
dc.date.issued2006
dc.departmentDicle Üniversitesien_US
dc.description108th Annual Meeting of the American-Academy-of-Otolaryngology-Head-and-Neck-Surgery-Foundation -- SEP 19-22, 2004 -- New York, NYen_US
dc.description.abstractObjective: To investigate the efficacy of medical antituberculous treatment in patients with tuberculous cervical lymphadenitis (TCL). Methods: In the period 1996-2002, 73 TCL patients were reviewed and the results of clinical and laboratory testing were documented. The efficacy of a four-drug chemotherapy regimen was investigated. Results: Purified protein derivatives (PPD) skin test results were positive in 58 (79 per cent) patients. Chest X-rays revealed changes consistent with tuberculosis in nine (12.3 per cent) patients. The mean duration of medical treatment was 10.04 months. In follow-up evaluation, 14 (20 per cent) patients were considered suspicious for resistant TCL and total excision of all nodes was performed. Histopathology confirmed TB in only 10 of these cases. Conclusion: The high incidence of residual disease in our study indicates that medical treatment (at least nine months of four combined antituberculous drugs) did not seem to be effective. If lymphadenopathy persists, total surgical excision of lymph nodes should be the treatment of choice.en_US
dc.description.sponsorshipAmer Acad Otolaryngol Head & Neck Surg Fdnen_US
dc.identifier.doi10.1017/S002221510500277X
dc.identifier.endpage132en_US
dc.identifier.issn0022-2151
dc.identifier.issn1748-5460
dc.identifier.issue2en_US
dc.identifier.pmid16359138
dc.identifier.scopus2-s2.0-33746097437
dc.identifier.scopusqualityQ2
dc.identifier.startpage129en_US
dc.identifier.urihttps://doi.org/10.1017/S002221510500277X
dc.identifier.urihttps://hdl.handle.net/11468/16378
dc.identifier.volume120en_US
dc.identifier.wosWOS:000235786000010
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherCambridge Univ Pressen_US
dc.relation.ispartofJournal of Laryngology and Otology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMycobacterium Tuberculosisen_US
dc.subjectNecken_US
dc.subjectLymph Nodesen_US
dc.subjectFollow-Up Studiesen_US
dc.titleFollow-up results in tuberculous cervical lymphadenitisen_US
dc.titleFollow-up results in tuberculous cervical lymphadenitis
dc.typeConference Objecten_US

Dosyalar